![](https://corporate.webassets.siemens-healthineers.com/e488e81d86f8484e/612274b4988d/v/c1be2ab28402/ct-lung.jpg)
Wenn COVID-19 zuschlägt, lernen wir aus den Spuren
Der führende KI-Wissenschaftler Bogdan Georgescu und sein Team entwickelten einen Algorithmus, der Klinikern künftig bei der Beurteilung hinsichtlich Schweregrad und Verlauf von COVID-19 von großem Nutzen sein könnte.
Auf den Spuren von COVID-19: Gemeinsam mit Kollegen aus aller Welt entwickelte ein Team einen Algorithmus, der dabei helfen soll, Veränderungen im Lungengewebe zu beurteilen. Eine Geschichte über einen wichtigen Meilenstein in Zeiten der Pandemie.
![AI scientist Bogdan Georgescu](https://corporate.webassets.siemens-healthineers.com/31ffd2cbfaeafdb7/339b36137910/v/8be09f5c3cf5/Bogdan-Georgescu.jpg)
![Image of the lung](https://corporate.webassets.siemens-healthineers.com/eb351a2a5ea8174d/18c001674b2b/v/3b8acfc55600/lung-image.jpg)
![Supercomputer "Sherlock"](https://corporate.webassets.siemens-healthineers.com/3e0c3438a2b76bc9/239e4f46814d/v/002e4dad9ddc/DPI-server-room-in-data-center.jpg)
Lösungen, die auf künstlicher Intelligenz basieren, können Radiologen entlasten, indem sie Experten Analysen für die weitere Beurteilung zur Verfügung stellen. Für die Radiologie bedeutet das mehr Effizienz.
Bogdan Georgescu
Algorithmen brauchen gutes Futter
![Pneumonia-analysis-research-results](https://corporate.webassets.siemens-healthineers.com/8f21d75ee595d28c/59ad98881c61/v/82af9c3b7e6c/Pneumonia-analysis-research-results.jpg)
Es ist aufregend zu wissen, dass unsere Arbeit dabei helfen kann, COVID-19 besser zu verstehen und in Zukunft möglicherweise effektiver bekämpfen zu können.
Bogdan Georgescu
1 This product is under development and not commercially available. Its future availability cannot be ensured.
2 The AI-Rad Companion Chest CT Pulmonary Density feature falls under the FDA Enforcement Policy for Imaging Systems during the Coronavirus Disease 2019 (COVID-19) Public Health Emergency Section IV.C and is therefore not 510(k) cleared. It is not intended to be used to diagnose COVID-19. AI-Rad Companion Chest CT is not commercially available in all countries. Its future availability cannot be guaranteed.
3 Image created with Cinematic Rendering, Courtesy of CHR East Belgium Verviers
- The development of the prototype algorithm and its deployment was a Siemens Healthineers collaborative effort, bringing together frontline healthcare providers, scientists and engineers from Princeton, clinical experts and developers from India, product development teams from CT, Digital Health and Syngo from Germany. The Pulmonary Density feature is new in VA12A without FDA Clearance. According to FDA policy “Enforcement Policy for Imaging Systems During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency issued in April 2020, the manufacturer is allowed to market this feature without FDA-clearance. This policy is intended to remain in effect only for the duration of the public health emergency related to COVID-19 declared by the HHS Secretary in accordance with section 319(a)(2) of the Public Health Services Act (42 U.S.C. 247d(a)(2)). Pulmonary Density results are not indicated for the diagnosis of COVID-19. Only in vitro diagnostic testing is currently the definitive method to diagnose COVID-19.